- Home
- BTM vs RAPT Comparison
BTM vs RAPT Comparison
Compare BTM & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTM
- RAPT
- Stock Information
- Founded
- BTM 2016
- RAPT 2015
- Country
- BTM United States
- RAPT United States
- Employees
- BTM N/A
- RAPT N/A
- Industry
- BTM Finance: Consumer Services
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- BTM Finance
- RAPT Health Care
- Exchange
- BTM Nasdaq
- RAPT Nasdaq
- Market Cap
- BTM 144.5M
- RAPT 122.9M
- IPO Year
- BTM N/A
- RAPT 2019
- Fundamental
- Price
- BTM $4.64
- RAPT $10.49
- Analyst Decision
- BTM Strong Buy
- RAPT Buy
- Analyst Count
- BTM 2
- RAPT 5
- Target Price
- BTM $4.75
- RAPT $32.20
- AVG Volume (30 Days)
- BTM 1.4M
- RAPT 100.1K
- Earning Date
- BTM 08-12-2025
- RAPT 08-11-2025
- Dividend Yield
- BTM N/A
- RAPT N/A
- EPS Growth
- BTM N/A
- RAPT N/A
- EPS
- BTM N/A
- RAPT N/A
- Revenue
- BTM $599,390,000.00
- RAPT N/A
- Revenue This Year
- BTM $10.59
- RAPT N/A
- Revenue Next Year
- BTM $4.27
- RAPT N/A
- P/E Ratio
- BTM N/A
- RAPT N/A
- Revenue Growth
- BTM N/A
- RAPT N/A
- 52 Week Low
- BTM $0.93
- RAPT $5.67
- 52 Week High
- BTM $6.88
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- BTM 38.34
- RAPT 50.12
- Support Level
- BTM $4.90
- RAPT $11.15
- Resistance Level
- BTM $5.70
- RAPT $13.50
- Average True Range (ATR)
- BTM 0.42
- RAPT 1.22
- MACD
- BTM -0.14
- RAPT -0.17
- Stochastic Oscillator
- BTM 3.15
- RAPT 28.71
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.